North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath.
The trust, which serves a catchment of 800,000 patients in North Cambridgeshire and South Lincolnshire, found itself with two LIMS when it was formed out of the merger of Peterborough and Stamford Hospitals and Hinchingbrooke Health Care in 2017.
Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to offer a comprehensive approach to patient journey management.
Effective management of a patient’s journey requires a systemwide approach, from specialist referrals to inpatient admissions through to discharge. Key to this improvement is making data easily accessible and mobile, engaging clinicians, and predicting bottlenecks in the system.
Homerton Healthcare NHS Foundation Trust has become the first organisation anywhere in the NHS to deploy Sectra's enterprise imaging service using public cloud.
The deployment has shown that NHS patient imaging can be efficiently accessed from a secure public cloud environment, just as quickly as when data is stored on-premise.
The six NHS health boards across the North of Scotland have gone live with a joint electronic medicines management platform to enhance clinical decision-making and reduce the risk of errors. The first ever multi-locality deployment of System C's pharmacy stock control (PSC) and hospital electronic prescribing medicines administration (HEPMA) systems will benefit over 25,000 staff across 66 hospitals and 5,163 beds. A systemic cause of patient harm could be better avoided with the help of technology, following the launch of Miya Results Tracking by health tech company Alcidion.
The new digital solution is designed to reduce the risk of test results not being followed up. It has been built to help healthcare professionals in hospital settings to more easily visualise, prioritise and acknowledge high volumes of tests results generated for patients every day, and to take appropriate action in a timely manner.
Bayer moves ahead with advancements across its comprehensive Radiology portfolio as well as expanded offering in its digital business and services. The company announced that new clinical and pre-clinical data for gadoquatrane, Bayer's novel investigational macrocyclic gadolinium-based contrast agent currently in Phase III clinical development, will be presented at the 2024 European Congress of Radiology (ECR) - taking place from February 28 to March 3, 2024, in Vienna, Austria. 
Mid and South Essex Integrated Care System (MSE ICS) is working with Orion Health on a shared care record that will help it to address some of the most pressing health and social care issues faced by its population.
To support the development of the shared care record, the ICS and Orion Health are adopting an innovative strategy that focuses on solving real-world problems.